Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in SYRE — Spyre Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$262,864,706
+$182,224,766 QoQ
Shares Held
2,960,855
+85.2% QoQ
Ownership
3.36%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#9
of 266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. SYRE ranks #18 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $262,864,706 2,960,855
2026-03-31 $80,639,940 1,598,730
2025-12-31 $52,477,654 1,601,882
2025-09-30 $10,401,590 620,620
2025-06-30 $13,929,300 930,481
2025-03-31 $4,010,224 248,542
2024-12-31 $11,790,155 506,450
2024-09-30 $12,620,624 429,127
2024-06-30 $7,240,514 307,976
2024-03-31 $2,978,604 78,529